Novel alicyclic imidazoles as h3 agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4164 (2006.01) C07D 233/54 (2006.01) C07D 233/64 (2006.01)

Patent

CA 2419073

Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine H3 receptors are involved, such as allergy, inflammation, hypotension, glaucoma, sleeping disorders, states of hyper- and hypo-motility of the gastro-intestinal tract, cardiovascular disease, hypo- and hyper-activity of the central nervous system, Alzheimer's, schizophrenia, obesity and migraines are disclosed.

L'invention concerne des composés d'imidazole alicyclique, des compositions pharmaceutiquement actives contenant ces composés, et l'utilisation de ces composés dans des préparations de traitement ou de prévention d'états pathologiques dans lesquels interviennent les récepteurs de l'histamine H¿3?, tels que l'allergie, l'inflammation, l'hypotension, le glaucome, les troubles du sommeil, les états d'hyper- ou d'hypomotilité du tractus gastro-intestinal, les maladies cardiovasculaires, les états d'hypo- ou d'hyperactivité du système nerveux central, la maladie d'Alzheimer, la schizophrénie, l'obésité ou les migraines.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel alicyclic imidazoles as h3 agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel alicyclic imidazoles as h3 agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel alicyclic imidazoles as h3 agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014002

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.